The role of FAK in tumor metabolism and therapy

Pharmacology and Therapeutics

Volumn 142, Issue 2, 2014, Pages 154-163

  Zhang, Jianliang ^a   Hochwald, Steven N ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Focal adhesion kinase; Glutamine; Lipogenesis; Molecular targeting; Motility; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; AVE 1642; AXL 1717; DALOTUZUMAB; EVEROLIMUS; FIGITUMUMAB; FOCAL ADHESION KINASE; FOCAL ADHESION KINASE INHIBITOR; GANITUMAB; GLUCOSE; GLUTAMINE; GSK 2256098; LINSITINIB; LIPID; PACLITAXEL; R 1507; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; VS 4718; VS 6063; XL 228;

CANCER CELL; CANCER RISK; CARCINOGENESIS; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DEREGULATION; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; LIPID METABOLISM; LIPOGENESIS; METABOLISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR GROWTH; TUMOR INVASION;

FOCAL ADHESION KINASE; GLUTAMINE; LIPOGENESIS; MOLECULAR TARGETING; MOTILITY; PROLIFERATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DRUG DESIGN; ENERGY METABOLISM; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASMS; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 84896390056     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.12.003     Document Type: Review

References (147)

1. (ECCO), T. E. C. O. Mesothelioma drug slows disease progression in patients with an inactive NF2 gene Science Daily 2012
2. M. Ackermann, B.A. Morse, V. Delventhal, I.M. Carvajal, and M.A. Konerding Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture Angiogenesis 15 2012 685 695
3. K. Aleksandrova, H. Boeing, M. Jenab, H. Bas Bueno-de-Mesquita, E. Jansen, and F.J. van Duijnhoven et al. Metabolic syndrome and risks of colon and rectal cancer: the European prospective investigation into cancer and nutrition study Cancer Prev Res (Phila) 4 2011 1873 1883
4. S. Andersson, P. D'Arcy, O. Larsson, and B. Sehat Focal adhesion kinase (FAK) activates and stabilizes IGF-1 receptor Biochem Biophys Res Commun 387 2009 36 41
5. E. Anichini, A. Zamperini, M. Chevanne, R. Caldini, M. Pucci, and G. Fibbi et al. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters Biochemistry 36 1997 3076 3083
6. A.G. Aprikian, L. Tremblay, K. Han, and S. Chevalier Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins Int J Cancer 72 1997 498 504
7. M.S. Aronsohn, H.M. Brown, G. Hauptman, and L.J. Kornberg Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx Laryngoscope 113 2003 1944 1948
8. V. Baron, V. Calleja, P. Ferrari, F. Alengrin, and E. Van Obberghen p125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors J Biol Chem 273 1998 7162 7168
9. E.A. Beierle, A. Trujillo, A. Nagaram, E.V. Kurenova, R. Finch, and X. Ma et al. N-MYC regulates focal adhesion kinase expression in human neuroblastoma J Biol Chem 282 2007 12503 12516
10. L. Berlicki Inhibitors of glutamine synthetase and their potential application in medicine Mini Rev Med Chem 8 2008 869 878
11. C. Bernstein, H. Holubec, A.K. Bhattacharyya, H. Nguyen, C.M. Payne, and B. Zaitlin et al. Carcinogenicity of deoxycholate, a secondary bile acid Arch Toxicol 85 2011 863 871
12. B. Bisht, and C.S. Dey Focal adhesion kinase contributes to insulin-induced actin reorganization into a mesh harboring glucose transporter-4 in insulin resistant skeletal muscle cells BMC Cell Biol 9 2008 48
13. R.W. Brownsey, N.J. Edgell, T.J. Hopkirk, and R.M. Denton Studies on insulin-stimulated phosphorylation of acetyl-CoA carboxylase, ATP citrate lyase and other proteins in rat epididymal adipose tissue. Evidence for activation of a cyclic AMP-independent protein kinase Biochem J 218 1984 733 743
14. F. Cai, Y.M. Dupertuis, and C. Pichard Role of polyunsaturated fatty acids and lipid peroxidation on colorectal cancer risk and treatments Curr Opin Clin Nutr Metab Care 15 2012 99 106
15. W.G. Cance, J.E. Harris, M.V. Iacocca, E. Roche, X. Yang, and J. Chang et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes Clin Cancer Res 6 2000 2417 2423
16. H.W. Chen, Y.F. Chang, H.Y. Chuang, W.T. Tai, and J.J. Hwang Targeted therapy with fatty acid synthase inhibitors in a human prostate carcinoma LNCaP/tk-luc-bearing animal model Prostate Cancer Prostatic Dis 15 2012 260 264
17. A. Chocarro-Calvo, J.M. Garcia-Martinez, S. Ardila-Gonzalez, A. De la Vieja, and C. Garcia-Jimenez Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer Mol Cell 49 2013 474 486
18. I. Crespo, B. San-Miguel, C. Prause, N. Marroni, M.J. Cuevas, and J. Gonzalez-Gallego et al. Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis PLoS One 7 2012 e50407
19. C.V. Dang MYC, metabolism, cell growth, and tumorigenesis Cold Spring Harb Perspect Med 3 2013
20. P. Dao, R. Jarray, J. Le Coq, D. Lietha, A. Loukaci, and Y. Lepelletier et al. Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity Bioorg Med Chem Lett 23 2013 4552 4556
21. K.B. Dunn, M. Heffler, and V.M. Golubovskaya Evolving therapies and FAK inhibitors for the treatment of cancer Anticancer Agents Med Chem 10 2010 722 734
22. S. El Annabi, N. Gautier, and V. Baron Focal adhesion kinase and Src mediate integrin regulation of insulin receptor phosphorylation FEBS Lett 507 2001 247 252
23. P.J. Fernandez-Marcos, and M. Serrano Sirt4: the glutamine gatekeeper Cancer Cell 23 2013 427 428
24. D.A. Fletcher, and R.D. Mullins Cell mechanics and the cytoskeleton Nature 463 2010 485 492
25. Y.M. Fu, Z.X. Yu, Y.Q. Li, X. Ge, P.J. Sanchez, and X. Fu et al. Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells Nutr Cancer 45 2003 60 73
26. Y.M. Fu, Z.X. Yu, B.A. Pelayo, V.J. Ferrans, and G.G. Meadows Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency Cancer Res 59 1999 758 765
27. Y.M. Fu, H. Zhang, M. Ding, Y.Q. Li, X. Fu, and Z.X. Yu et al. Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling Clin Exp Metastasis 21 2004 587 598
28. R.E. Gates, L.E. King Jr., S.K. Hanks, and L.B. Nanney Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture Cell Growth Differ 5 1994 891 899
29. F.G. Gervais, N.A. Thornberry, S.C. Ruffolo, D.W. Nicholson, and S. Roy Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide J Biol Chem 273 1998 17102 17108
30. H.L. Goel, and C.S. Dey Focal adhesion kinase tyrosine phosphorylation is associated with myogenesis and modulated by insulin Cell Prolif 35 2002 131 142
31. V.M. Golubovskaya, S. Figel, B.T. Ho, C.P. Johnson, M. Yemma, and G. Huang et al. A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo Carcinogenesis 33 2012 1004 1013
32. V.M. Golubovskaya, F.A. Kweh, and W.G. Cance Focal adhesion kinase and cancer Histol Histopathol 24 2009 503 510
33. V.M. Golubovskaya, C. Nyberg, M. Zheng, F. Kweh, A. Magis, and D. Ostrov et al. A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth J Med Chem 51 2008 7405 7416
34. N.A. Graham, M. Tahmasian, B. Kohli, E. Komisopoulou, M. Zhu, and I. Vivanco et al. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death Mol Syst Biol 8 2012 589
35. J.L. Guan, and D. Shalloway Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation Nature 358 1992 690 692
36. D. Guo, E.H. Bell, P. Mischel, and A. Chakravarti Targeting SREBP-1-driven lipid metabolism to treat cancer Curr Pharm Des 2013 (in press)
37. A. Gupta, B. Bisht, and C.S. Dey Focal adhesion kinase negatively regulates neuronal insulin resistance Biochim Biophys Acta 1822 2012 1030 1037
38. M. Hassanein, M.D. Hoeksema, M. Shiota, J. Qian, B.K. Harris, and H. Chen et al. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival Clin Cancer Res 19 2013 560 570
39. C.R. Hauck, D.A. Hsia, and D.D. Schlaepfer The focal adhesion kinase - a regulator of cell migration and invasion IUBMB Life 53 2002 115 119
40. M. Hewish, I. Chau, and D. Cunningham Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine Recent Pat Anticancer Drug Discov 4 2009 54 72
41. S.N. Hochwald, C. Nyberg, M. Zheng, D. Zheng, C. Wood, and N.A. Massoll et al. A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer Cell Cycle 8 2009 2435 2443
42. D. Huang, A.T. Cheung, J.T. Parsons, and M. Bryer-Ash Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes J Biol Chem 277 2002 18151 18160
43. J.R. Infante, D.R. Camidge, L.R. Mileshkin, E.X. Chen, R.J. Hicks, and D. Rischin et al. Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors J Clin Oncol 30 2012 1527 1533
44. S. Itoh, T. Maeda, M. Shimada, S. Aishima, K. Shirabe, and S. Tanaka et al. Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma Clin Cancer Res 10 2004 2812 2817
45. F. Janku, H.J. Huang, L.S. Angelo, and R. Kurzrock A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R): implications for inhibition of the IGF-1R signal Oncotarget 4 2013 463 473
46. J.H. Jeon, S.K. Kim, H.J. Kim, J. Chang, C.M. Ahn, and Y.S. Chang Lipid raft modulation inhibits NSCLC cell migration through delocalization of the focal adhesion complex Lung Cancer 69 2010 165 171
47. J. Jeon, H. Lee, H. Park, J.H. Lee, S. Choi, and J. Hwang et al. Phosphorylation of focal adhesion kinase at Tyrosine 407 negatively regulates Ras transformation of fibroblasts Biochem Biophys Res Commun 364 2007 1062 1066
48. S.M. Jeong, C. Xiao, L.W. Finley, T. Lahusen, A.L. Souza, and K. Pierce et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism Cancer Cell 23 2013 450 463
49. G.C. Kabat, M.Y. Kim, H.D. Strickler, J.M. Shikany, D. Lane, and J. Luo et al. A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women Br J Cancer 106 2012 227 232
50. G. Kallergi, D. Mavroudis, V. Georgoulias, and C. Stournaras Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells Mol Med 13 2007 79 88
51. S. Khare, C. Holgren, and A.M. Samarel Deoxycholic acid differentially regulates focal adhesion kinase phosphorylation: role of tyrosine phosphatase ShP2 Am J Physiol Gastrointest Liver Physiol 291 2006 G1100 G1112
52. S. Kim, H. Kim do, W.H. Jung, and J.S. Koo Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer Endocr Relat Cancer 20 2013 339 348
53. S.J. Kim, J.W. Park, J.S. Yoon, J.O. Mok, Y.J. Kim, and H.K. Park et al. Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study J Korean Med Sci 19 2004 710 715
54. J.B. Knight, K. Yamauchi, and J.E. Pessin Divergent insulin and platelet-derived growth factor regulation of focal adhesion kinase (pp125FAK) tyrosine phosphorylation, and rearrangement of actin stress fibers J Biol Chem 270 1995 10199 10203
55. Y.H. Ko, Z. Lin, N. Flomenberg, R.G. Pestell, A. Howell, and F. Sotgia et al. Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells: implications for preventing chemotherapy resistance Cancer Biol Ther 12 2011 1085 1097
56. G. Kroder, B. Bossenmaier, M. Kellerer, E. Capp, B. Stoyanov, and A. Muhlhofer et al. Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling J Clin Invest 97 1996 1471 1477
57. J.E. Kucab, and S.E. Dunn Role of IGF-1R in mediating breast cancer invasion and metastasis Breast Dis 17 2003 41 47
58. J.F. Kuemmerle Insulin-like growth factors in the gastrointestinal tract and liver Endocrinol Metab Clin North Am 41 2012 409 423 (vii)
59. E.V. Kurenova, D.L. Hunt, D. He, A.T. Magis, D.A. Ostrov, and W.G. Cance Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo J Med Chem 52 2009 4716 4724
60. L. Kwong, M.A. Wozniak, A.S. Collins, S.D. Wilson, and P.J. Keely R-Ras promotes focal adhesion formation through focal adhesion kinase and p130(Cas) by a novel mechanism that differs from integrins Mol Cell Biol 23 2003 933 949
61. M.Q. Lacy, M. Alsina, R. Fonseca, M.L. Paccagnella, C.L. Melvin, and D. Yin et al. Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 receptor monoclonal antibody CP-751,871 in patients with multiple myeloma J Clin Oncol 26 2008 3196 3203
62. I.R. Lai, P.Y. Chu, H.S. Lin, J.Y. Liou, Y.J. Jan, and J.C. Lee et al. Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance Am J Pathol 177 2010 1629 1637
63. A.L. Lark, C.A. Livasy, L. Dressler, D.T. Moore, R.C. Millikan, and J. Geradts et al. High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype Mod Pathol 18 2005 1289 1294
64. Y. Le, M. Honczarenko, A.M. Glodek, D.K. Ho, and L.E. Silberstein CXC chemokine ligand 12-induced focal adhesion kinase activation and segregation into membrane domains is modulated by regulator of G protein signaling 1 in pro-B cells J Immunol 174 2005 2582 2590
65. P. Lebrun, V. Baron, C.R. Hauck, D.D. Schlaepfer, and E. Van Obberghen Cell adhesion and focal adhesion kinase regulate insulin receptor substrate-1 expression J Biol Chem 275 2000 38371 38377
66. F. Lehembre, M. Yilmaz, A. Wicki, T. Schomber, K. Strittmatter, and D. Ziegler et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin EMBO J 27 2008 2603 2615
67. D. Lietha, X. Cai, D.F. Ceccarelli, Y. Li, M.D. Schaller, and M.J. Eck Structural basis for the autoinhibition of focal adhesion kinase Cell 129 2007 1177 1187
68. W. Liu, D.A. Bloom, W.G. Cance, E.V. Kurenova, V.M. Golubovskaya, and S.N. Hochwald FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells Carcinogenesis 29 2008 1096 1107
69. W.M. Liu, P. Huang, N. Kar, M. Burgett, G. Muller-Greven, and A.S. Nowacki et al. Lyn facilitates glioblastoma cell survival under conditions of nutrient deprivation by promoting autophagy PLoS One 8 2013 e70804
70. T.J. Liu, T. LaFortune, T. Honda, O. Ohmori, S. Hatakeyama, and T. Meyer et al. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo Mol Cancer Ther 6 2007 1357 1367
71. G. Liu, X. Meng, Y. Jin, J. Bai, Y. Zhao, and X. Cui et al. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549 Cell Biol Int 32 2008 663 670
72. C. Lobo, M.A. Ruiz-Bellido, J.C. Aledo, J. Marquez, I. Nunez De Castro, and F.J. Alonso Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells Biochem J 348 Pt 2 2000 257 261
73. W.W. Ma Development of focal adhesion kinase inhibitors in cancer therapy Anticancer Agents Med Chem 11 2011 638 642
74. A.J. McMichael, and J.D. Potter Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer J Natl Cancer Inst 75 1985 185 191
75. E. Menu, H. Jernberg-Wiklund, H. De Raeve, E. De Leenheer, L. Coulton, and O. Gallagher et al. Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: beneficial effects on tumor growth, angiogenesis, bone disease and survival Int J Cancer 121 2007 1857 1861
76. T. Migita, T. Narita, K. Nomura, E. Miyagi, F. Inazuka, and M. Matsuura et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer Cancer Res 68 2008 8547 8554
77. T. Migita, S. Okabe, K. Ikeda, S. Igarashi, S. Sugawara, and A. Tomida et al. Inhibition of ATP citrate lyase induces an anticancer effect via reactive oxygen species: AMPK as a predictive biomarker for therapeutic impact Am J Pathol 182 2013 1800 1810
78. K. Moissoglu, and I.H. Gelman v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts J Biol Chem 278 2003 47946 47959
79. L.R. Molife, P.C. Fong, L. Paccagnella, A.H. Reid, H.M. Shaw, and L. Vidal et al. The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study Br J Cancer 103 2010 332 339
80. C. Moser, P. Schachtschneider, S.A. Lang, A. Gaumann, A. Mori, and J. Zimmermann et al. Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis Eur J Cancer 44 2008 1577 1586
81. M.W. Musch, D. Hayden, K. Sugi, D. Straus, and E.B. Chang Cell-specific induction of hsp72-mediated protection by glutamine against oxidant injury in IEC18 cells Proc Assoc Am Physicians 110 1998 136 139
82. K. Nagaharu, X. Zhang, T. Yoshida, D. Katoh, N. Hanamura, and Y. Kozuka et al. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells Am J Pathol 178 2011 754 763
83. P. Nicklin, P. Bergman, B. Zhang, E. Triantafellow, H. Wang, and B. Nyfeler et al. Bidirectional transport of amino acids regulates mTOR and autophagy Cell 136 2009 521 534
84. B.N. Nicolay, P.A. Gameiro, K. Tschop, M. Korenjak, A.M. Heilmann, and J.M. Asara et al. Loss of RBF1 changes glutamine catabolism Genes Dev 27 2013 182 196
85. P. Niethammer, M. Delling, V. Sytnyk, A. Dityatev, K. Fukami, and M. Schachner Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis J Cell Biol 157 2002 521 532
86. S. Ocak, H. Chen, C. Callison, A.L. Gonzalez, and P.P. Massion Expression of focal adhesion kinase in small-cell lung carcinoma Cancer 118 2012 1293 1301
87. D.M. Ouwens, H.M. Mikkers, G.C. van der Zon, M. Stein-Gerlach, A. Ullrich, and J.A. Maassen Insulin-induced tyrosine dephosphorylation of paxillin and focal adhesion kinase requires active phosphotyrosine phosphatase 1D Biochem J 318 Pt 2 1996 609 614
88. 18F-FDG uptake through focal adhesion kinase-mediated phosphatidylinositol 3-kinase/Akt signaling J Nucl Med 50 2009 618 624
89. P.R. Pandey, W. Liu, F. Xing, K. Fukuda, and K. Watabe Anti-cancer drugs targeting fatty acid synthase (FAS) Recent Pat Anticancer Drug Discov 7 2012 185 197
90. J.H. Park, and H.J. Han Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK Am J Physiol Cell Physiol 297 2009 C935 C944
91. E.K. Park, M.J. Park, S.H. Lee, Y.C. Li, J. Kim, and J.S. Lee et al. Cholesterol depletion induces anoikis-like apoptosis via FAK down-regulation and caveolae internalization J Pathol 218 2009 337 349
92. J.H. Park, J.M. Ryu, and H.J. Han Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways J Cell Physiol 226 2011 267 275
93. T.S. Pillay, T. Sasaoka, and J.M. Olefsky Insulin stimulates the tyrosine dephosphorylation of pp 125 focal adhesion kinase J Biol Chem 270 1995 991 994
94. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
95. T. Putz, Z. Culig, I.E. Eder, C. Nessler-Menardi, G. Bartsch, and H. Grunicke et al. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines Cancer Res 59 1999 227 233
96. O.G. Ramprasad, G. Srinivas, K.S. Rao, P. Joshi, J.P. Thiery, and S. Dufour et al. Changes in cholesterol levels in the plasma membrane modulate cell signaling and regulate cell adhesion and migration on fibronectin Cell Motil Cytoskeleton 64 2007 199 216
97. J.P. Raufman, J. Shant, C.Y. Guo, S. Roy, and K. Cheng Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling J Cell Physiol 215 2008 538 549
98. J.L. Resnik, D.B. Reichart, K. Huey, N.J. Webster, and B.L. Seely Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer Cancer Res 58 1998 1159 1164
99. N.D. Ridgway The role of phosphatidylcholine and choline metabolites to cell proliferation and survival Crit Rev Biochem Mol Biol 48 2013 20 38
100. M. Ritt, J.L. Guan, and S. Sivaramakrishnan Visualizing and manipulating focal adhesion kinase regulation in live cells J Biol Chem 288 2013 8875 8886
101. J.D. Rovin, H.F. Frierson Jr., W. Ledinh, J.T. Parsons, and R.B. Adams Expression of focal adhesion kinase in normal and pathologic human prostate tissues Prostate 53 2002 124 132
102. T. Sakiyama, M.W. Musch, M.J. Ropeleski, H. Tsubouchi, and E.B. Chang Glutamine increases autophagy under basal and stressed conditions in intestinal epithelial cells Gastroenterology 136 2009 924 932
103. G.V. Scagliotti, and S. Novello The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors Cancer Treat Rev 38 2012 292 302
104. D.D. Schlaepfer, S.K. Hanks, T. Hunter, and P. van der Geer Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase Nature 372 1994 786 791
105. G.B. Schneider, Z. Kurago, R. Zaharias, L.M. Gruman, M.D. Schaller, and M.J. Hendrix Elevated focal adhesion kinase expression facilitates oral tumor cell invasion Cancer 95 2002 2508 2515
106. A. Schultze, and W. Fiedler Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer Expert Opin Investig Drugs 19 2010 777 788
107. A. Schultze, and W. Fiedler Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase Anticancer Agents Med Chem 11 2011 593 599
108. A. Serrels, K. McLeod, M. Canel, A. Kinnaird, K. Graham, and M.C. Frame et al. The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells Int J Cancer 131 2012 287 297
109. Y. Shang, Y. Mao, J. Batson, S.J. Scales, G. Phillips, and M.R. Lackner et al. Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake Mol Cancer Ther 7 2008 2599 2608
110. T. Shima, S. Nada, and M. Okada Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts Proc Natl Acad Sci U S A 100 2003 14897 14902
111. M.S. Simon, C.A. Rosenberg, R.J. Rodabough, P. Greenland, I. Ockene, and H.K. Roy et al. Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk Ann Epidemiol 22 2012 17 27
112. N.E. Simpson, V.P. Tryndyak, M. Pogribna, F.A. Beland, and I.P. Pogribny Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype Epigenetics 7 2012 1413 1420
113. J. Son, C.A. Lyssiotis, H. Ying, X. Wang, S. Hua, and M. Ligorio et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway Nature 496 2013 101 105
114. B. Su, L. Gao, F. Meng, L.W. Guo, J. Rothschild, and I.H. Gelman Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12 Oncogene 32 2013 2016 2026
115. M. Tamura, A. Osajima, S. Nakayamada, H. Anai, N. Kabashima, and K. Kanegae et al. High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells Kidney Int 63 2003 722 731
116. S. Tardito, M. Chiu, J. Uggeri, A. Zerbini, F. Da Ros, and V. Dall'Asta et al. l-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of beta-catenin-mutated human hepatocellular carcinoma cells Curr Cancer Drug Targets 11 2011 929 943
117. K. Thangavelu, C.Q. Pan, T. Karlberg, G. Balaji, M. Uttamchandani, and V. Suresh et al. Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism Proc Natl Acad Sci U S A 109 2012 7705 7710
118. N. Tomita, Y. Hayashi, S. Suzuki, Y. Oomori, Y. Aramaki, and Y. Matsushita et al. Structure-based discovery of cellular-active allosteric inhibitors of FAK Bioorg Med Chem Lett 23 2013 1779 1785
119. D.A. Ucar, and S.N. Hochwald FAK and interacting proteins as therapeutic targets in pancreatic cancer Anticancer Agents Med Chem 10 2010 742 746
120. D.A. Ucar, E. Kurenova, T.J. Garrett, W.G. Cance, C. Nyberg, and A. Cox et al. Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth Cell Cycle 11 2012 3250 3259
121. D.A. Ucar, A.T. Magis, D.H. He, N.J. Lawrence, S.M. Sebti, and E. Kurenova et al. Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo Anticancer Agents Med Chem 13 2013 595 602
122. R.K. Vadlamudi, A.A. Sahin, L. Adam, R.A. Wang, and R. Kumar Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215 FEBS Lett 543 2003 76 80
123. K.E. van der Vos, P. Eliasson, T. Proikas-Cezanne, S.J. Vervoort, R. van Boxtel, and M. Putker et al. Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy Nat Cell Biol 14 2012 829 837
124. F.J. van Duijnhoven, H.B. Bueno-De-Mesquita, M. Calligaro, M. Jenab, T. Pischon, and E.H. Jansen et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European prospective investigation into cancer and nutrition Gut 60 2011 1094 1102
125. M. Van Hemelrijck, H. Garmo, N. Hammar, I. Jungner, G. Walldius, and M. Lambe et al. The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study Int J Cancer 130 2012 2118 2128
126. S. Van Slambrouck, C. Grijelmo, O. De Wever, E. Bruyneel, S. Emami, and C. Gespach et al. Activation of the FAK-src molecular scaffolds and p130Cas-JNK signaling cascades by alpha1-integrins during colon cancer cell invasion Int J Oncol 31 2007 1501 1508
127. M.G. Vander Heiden Targeting cancer metabolism: a therapeutic window opens Nat Rev Drug Discov 10 2011 671 684
128. A. Varis, M. Wolf, O. Monni, M.L. Vakkari, A. Kokkola, and C. Moskaluk et al. Targets of gene amplification and overexpression at 17q in gastric cancer Cancer Res 62 2002 2625 2629
129. T. Vartanian, A. Goodearl, S. Lefebvre, S.K. Park, and G. Fischbach Neuregulin induces the rapid association of focal adhesion kinase with the erbB2-erbB3 receptor complex in Schwann cells Biochem Biophys Res Commun 271 2000 414 417
130. R. Wade, N. Brimer, C. Lyons, and S. Vande Pol Paxillin enables attachment-independent tyrosine phosphorylation of focal adhesion kinase and transformation by RAS J Biol Chem 286 2011 37932 37944
131. J. Wang, D. Scholtens, M. Holko, D. Ivancic, O. Lee, and H. Hu et al. Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer Cancer Prev Res (Phila) 6 2013 321 330
132. G.S. Warshamana-Greene, J. Litz, E. Buchdunger, C. Garcia-Echeverria, F. Hofmann, and G.W. Krystal The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy Clin Cancer Res 11 2005 1563 1571
133. N. Watanabe, M. Takaoka, K. Sakurama, Y. Tomono, S. Hatakeyama, and O. Ohmori et al. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo Clin Cancer Res 14 2008 4631 4639
134. K.F. Wilson, J.W. Erickson, M.A. Antonyak, and R.A. Cerione Rho GTPases and their roles in cancer metabolism Trends Mol Med 19 2013 74 82
135. D.R. Wise, R.J. DeBerardinis, A. Mancuso, N. Sayed, X.Y. Zhang, and H.K. Pfeiffer et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc Natl Acad Sci U S A 105 2008 18782 18787
136. D.R. Wise, and C.B. Thompson Glutamine addiction: a new therapeutic target in cancer Trends Biochem Sci 35 2010 427 433
137. W. Wulaningsih, H. Garmo, L. Holmberg, N. Hammar, I. Jungner, and G. Walldius et al. Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study J Cancer Epidemiol 2012 2012 792034
138. W. Wulaningsih, L. Holmberg, H. Garmo, B. Zethelius, A. Wigertz, and P. Carroll et al. Serum glucose and fructosamine in relation to risk of cancer PLoS One 8 2013 e54944
139. H.F. Yancy, J.A. Mason, S. Peters, C.E. Thompson III, G.K. Littleton, and M. Jett et al. Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women J Carcinog 6 2007 8
140. Z. Yuan, Q. Zheng, J. Fan, K.X. Ai, J. Chen, and X.Y. Huang Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma J Cancer Res Clin Oncol 136 2010 1489 1496
141. I. Zachary, and E. Rozengurt Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes Cell 71 1992 891 894
142. N. Zaidi, J.V. Swinnen, and K. Smans ATP-citrate lyase: a key player in cancer metabolism Cancer Res 72 2012 3709 3714
143. Y.Y. Zaytseva, P.G. Rychahou, P. Gulhati, V.A. Elliott, W.C. Mustain, and K. O'Connor et al. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer Cancer Res 72 2012 1504 1517
144. J. Zhang, R. Francois, R. Iyer, M. Seshadri, M. Zajac-Kaye, and S.N. Hochwald Current understanding of the molecular biology of pancreatic neuroendocrine tumors J Natl Cancer Inst 105 2013 1005 1017
145. S. Zhang, Y. Luo, L.Q. He, Z.J. Liu, A.Q. Jiang, and Y.H. Yang et al. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity Bioorg Med Chem 21 2013 3723 3729
146. Z. Zhelev, R. Bakalova, H. Ohba, A. Ewis, M. Ishikawa, and Y. Shinohara et al. Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study) FEBS Lett 570 2004 195 204
147. D. Zheng, V. Golubovskaya, E. Kurenova, C. Wood, N.A. Massoll, and D. Ostrov et al. A novel strategy to inhibit FAK and IGF-1R decreases growth of pancreatic cancer xenografts Mol Carcinog 49 2010 200 209